Acorda Therapeutics | ACOR - Betriebsergebnis



Betriebsergebnis Veränderung Datum
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
ALKERMES USD -10.95M 100.03M 2025-12
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Amgen USD 3.96B 464M 2025-12
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD 40.81M 3.3M 2025-12
Biogen USD 514.3M 128.8M 2026-03
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Cara Therapeutics USD -5.94M 3.55M 2025-09
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD 56.04M 63.93M 2025-12
CSL USD 2.64B 1.97B 2025-12
Cytokinetics USD -178.37M 11.61M 2025-12
Enanta Pharmaceuticals USD -23.54M 98.15M 2024-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -249.71M 11.64M 2025-12
Ligand Pharmaceuticals USD 158.89M 149.17M 2025-09
MannKind USD -69.24M 28.19M 2025-12
Merck EUR 474M 738M 2025-12
Moderna USD -857M 597M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD 4.24B 171M 2026-03
Pfizer USD 4.65B 3.99B 2025-12
Sanofi EUR 1.94B 239M 2026-03
Teva Pharmaceutical Industries USD 758M 271M 2026-03
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12